๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Japan
Clinical trial register · Japan

Studies with a Japanese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2472 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:48 UTC
2472
Studies in scope
all four open statuses
1255
Recruiting now
open to new participants
347
Lead sponsors
across recruiting studies
Top sites
Fukuoka 550 Nagoya 510 Sapporo 402 Tokyo 363 Osaka 345
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca194 Eli Lilly and Company113 Novartis Pharmaceuticals102 Merck Sharp & Dohme LLC100 Pfizer98
Site location
Fukuoka550 Nagoya510 Sapporo402 Tokyo363 Osaka345
All 929 locations
Target enrolment
to

Trials in this register

2472 of 2472 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
NCT02674100Pancreatic Cancer
University of Louisville
Observational
500
Tokyo
2016-01
Active, closed
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
NCT02637687Solid Tumors Harboring NTRK Fusion
DrugLarotrectinib
Bayer
Phase 1/2
154
Yokohama, Chuo-ku, Fukuoka
2015-12-16
Active, closed
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
NCT02584933ALK Positive Malignancies
DrugCeritinib
Novartis Pharmaceuticals
Phase 4
233
Nagoya, Fukuoka, Akashi, Koto Ku
2015-12-11
Active, closed
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
NCT02489318Prostate Cancer
DrugApalutamide
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Chลซลku, Hakata-Ku, Koshigaya, Matsuyama, Minamiku, Miyazaki, Nagano, Nagasaki
2015-11-27
Active, closed
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
NCT02568267Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Head and Neck Neoplasms
DrugEntrectinib
Hoffmann-La Roche
Phase 2
534
Aichi, Chลซล, Hyลgo, Matsuyama, Miyagi, Niigata, Osaka, Shizuoka
2015-11-19
Active, closed
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
NCT02542293Non Small Cell Lung Carcinoma NSCLC
DrugsTremelimumab·Durvalumab·Pemetrexed·Gemcitabine
AstraZeneca
Phase 3
953
Bunkyล City, Fukushima, Habikino-shi, Hirosaki-shi, Iizuka-shi, Iwakuni-shi, Kanazawa, Kishiwada-shi
2015-11-03
Active, closed
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
NCT02516241Urothelial Cancer
DrugsTremelimumab·Durvalumab·Gemcitabine·Cisplatin
AstraZeneca
Phase 3
1,126
Akita, Bunkyล City, Fukuoka, Hakata-shi, Hirosaki-shi, Hiroshima, Izumo-shi, Kagoshima
2015-11-02
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,400
Fukuoka, Sapporo, Sendai, Chuo Ku, Kyoto
2015-11-02
Recruiting
Bleeding Rate After EGD and Colonoscopy in Patients Who Continue to Take Antithrombotic Agents
NCT02594813Bleeding After GI Endoscopy
Showa Inan General Hospital
Observational
10,000
Komagane
2015-11
Active, closed
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
NCT02486718Non-Small Cell Lung Cancer
DrugsVinorelbine·Tecentriq·Atezolizumab·Pemetrexed
Hoffmann-La Roche
Phase 3
1,280
Aichi, Akashi, Bunkyล City, Chลซล, Fukuoka, Hiroshima, Kitaadachi-gun, Kitakyushu-shi
2015-10-31
Active, closed
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
NCT02562235Hypertension, Pulmonary
DrugRiociguat
Bayer
Phase 3
24
ลŒbu, Suita, Shinjuku-ku
2015-10-29
Active, closed
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
NCT02511106Stage IB-IIIA Non-small Cell Lung Carcinoma
DrugOsimertinib
AstraZeneca
Phase 3
682
Bunkyล City, Fukuoka, Hirakata-shi, Hiroshima, Kanazawa, Kashiwa, Kitakyushu-shi, Kobe
2015-10-21
Active, closed
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
NCT02519348Hepatocellular Carcinoma
DrugsTremelimumab·Durvalumab·Bevacizumab
MedImmune LLC
Phase 2
433
Chลซลku, Kashiwa, Osakasayama-shi
2015-10-19
Recruiting
Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension ๏ผˆCTEPH๏ผ‰ Database in China
NCT05311072Chronic Thromboembolic Pulmonary Hypertension
China-Japan Friendship Hospital
Observational
1,500
2015-10-01
Active, closed
PALbociclib CoLlaborative Adjuvant Study
NCT02513394Breast Cancer
DrugPalbociclib
Alliance Foundation Trials, LLC.
Phase 3
5,796
Nagoya, Sapporo, Chiba, Kyoto, Osaka
2015-08
Active, closed
Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)
NCT02453282Non-Small-Cell Lung Carcinoma NSCLC
DrugsTremelimumab·Durvalumab·Pemetrexed·Gemcitabine
AstraZeneca
Phase 3
1,118
Fukushima, Himeji-shi, Hirakata-shi, Hirosaki-shi, Iizuka-shi, Iwakuni-shi, Izumi-shi, Kanazawa
2015-07-21
Active, closed
Micra Transcatheter Pacing System Post-Approval Registry
NCT02536118Bradycardia
Medtronic
Observational
3,100
Mitaka-shi, Shinagawa, Suita, Yokohama
2015-07
Active, closed
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naรฏve Unresectable Advanced or Recurrent Colorectal Cancer
NCT02394834Colorectal Cancer
Takeda
Observational
757
Ichinomiya, Komaki, Kounan, Nagakute, Nagoya, Okazaki, Toyohashi, Toyokawa
2015-05-29
Active, closed
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
NCT02411448Metastatic Non-Small Cell Lung Cancer
DrugsGefitinib·Erlotinib·Ramucirumab·Osimertinib
Eli Lilly and Company
Phase 3
545
Nagoya, Kashiwa, Tลon, Kurume, Asahikawa, Akashi, Amagashiki, Himeji
2015-05-06
Recruiting
C-Brace Prospective Registry
NCT04640584Pareses, Lower Extremity
Otto Bock Healthcare Products GmbH
Observational
250
Kobe
2015-04
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsJakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Nagoya, Sapporo, Isehara, Suita, Bunkyo Ku, Fukuoka, Osaka
2015-03-05
Active, closed
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
NCT02320435Solid Tumors
DrugsPerjeta·Pertuzumab·Trastuzumab
Hoffmann-La Roche
Phase 3
154
Chiba, Gifu, Saitama
2015-02-02
Active, closed
Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure
NCT06023134Right Heart Failure, Pulmonary Hypertension
Jingyi Ren
Observational
800
2015-01-01
Active, closed
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
NCT02912949Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
Partner Therapeutics, Inc.
Phase 2
250
Chลซลku, Kawasaki, Osaka, Tokyo
2015-01
Active, closed
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
NCT02308085Early Breast Cancer
ETOP IBCSG Partners Foundation
Not applicable
518
Amagasaki, Hamamatsu, Fukuoka, Kagoshima, Kawasaki, Kyoto, Matsuyama, Minato-ku, Tokyo
2014-12-04
Active, closed
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT02257736Prostatic Neoplasms
DrugsZytiga·Apalutamide·Abiraterone acetate·Prednisone
Aragon Pharmaceuticals, Inc.
Phase 3
982
Fukuoka, Kanazawa, Kashiwa, Kita-Gun, Kumamoto, Kurume, Matsuyama, Miyazaki
2014-11-26
Active, closed
A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
NCT02246621Breast Cancer
DrugsAnastrozole·Abemaciclib·Letrozole
Eli Lilly and Company
Phase 3
493
Nagoya, Chiba, Matsuyama, Sapporo, Nishinomiya, Yokohama, Niigata, ลŒsaka-sayama
2014-11-06
Active, closed
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
NCT02152631Non Small Cell Lung Cancer
DrugsErlotinib·Abemaciclib
Eli Lilly and Company
Phase 3
453
Amagasaki, Asahikawa, Bunkyล City, Fukuoka, Habikino, Hirakata, Hiroshima, Hyลgo
2014-10-03
Active, closed
AZD9291 in Combination With Ascending Doses of Novel Therapeutics
NCT02143466Advanced Non Small Cell Lung Cancer
DrugsSavolitinib·Selumetinib·Osimertinib·Durvalumab
AstraZeneca
Phase 1
344
Chลซลku, Habikino-shi, Hirakata-shi, Kashiwa, Nagoya
2014-08-05
Active, closed
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
NCT02107703Breast Neoplasms
DrugsAbemaciclib·Fulvestrant
Eli Lilly and Company
Phase 3
669
Nagoya, Chiba, Kashiwa, Matsuyama, Kurume, Sapporo, Nishinomiya, Kawasaki
2014-07-22
Active, closed
Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
NCT02185560Thyroid Carcinoma
DrugSorafenib
Bayer
Observational
453
Multiple Locations
2014-06-27
Recruiting
Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis
NCT02434003Scoliosis
St. Justine's Hospital
Observational
1,200
Nagoya
2014-05
Active, closed
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
NCT02032823Breast Cancer
DrugOlaparib
AstraZeneca
Phase 3
1,837
Chiba, Chลซลku, Fukuoka, Hidaka-shi, Hiroshima, Isehara-shi, Kagoshima, Kashiwa
2014-04-22
Active, closed
A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors
NCT02099058Advanced Solid Tumors Cancer
DrugsTelisotuzumab vedotin·Erlotinib·Osimertinib·Nivolumab
AbbVie
Phase 1
237
Kashiwa-shi, Chuo-ku
2014-01-15
Recruiting
International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
NCT02918032Neutral Lipid Storage Disease
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Observational
120
Suita, Kodaira
2014-01
Active, closed
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
NCT01946204Prostatic Neoplasms
DrugApalutamide
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Akita, Fukuoka, Gifu, Hakodate, Hiroshima, Hokkaido, Kanazawa, Kashiwa
2013-10-14
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
700
Bunkyล City, Hiroshima
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Akashi-shi, Chลซลku, Fukuoka, Hidaka-shi, Matsuyama, Niigata, Osakasayama-shi, Sapporo
2013-09-03
Recruiting
Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
NCT03138941Systemic Lupus Erythematosus
Monash University
Observational
5,000
Kitakyushu, Tokyo
2013-09-01
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Akashi-shi, Chลซลku, Fukuoka, Hidaka-shi, Matsuyama, Niigata, Sapporo, Sunto-gun
2013-08-26
Active, closed
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
NCT01872975Stage IB Breast Cancer, Stage II Breast Cancer
NSABP Foundation Inc
Not applicable
1,636
Sendai, Sapporo, Akashi, Morioka, Gunma, Niigata, Matsuyama, Saitama
2013-08
Recruiting
Japanese CTO PCI Expert Registry
NCT01889459Chronic Total Occlusion of Coronary Artery
Kurashiki Central Hospital
Observational
19,000
Kurashiki
2013-07
Recruiting
A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast
NCT02897700Breast Cancer
Shanghai Jiao Tong University School of Medicine
Phase 1
300
2013-01
Active, closed
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
NCT01760005Alzheimers Disease, Dementia, Alzheimers Disease, Familial
DrugsE2814·Lecanemab
Washington University School of Medicine
Phase 2/3
490
Niigata, Bunkyล City
2012-12
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
NCT01719055Pain
Boston Scientific Corporation
Observational
4,800
Kobe, Nishinomiya-shi, Okayama, Sakaishi
2012-11-19
Recruiting
Cardiac Sarcoidosis Multi-Center Prospective Cohort
NCT01477359Cardiac Sarcoidosis
Ottawa Heart Institute Research Corporation
Observational
1,500
Sapporo
2012-08
Recruiting
Phase III Trial of Stage I Ovarian Cancer After Surgery
NCT04063527Epithelial Ovarian Cancer
Japanese Gynecologic Oncology Group
Phase 3
360
Nagakute-shi, Seto-shi, Toyoake-shi, Hirosaki-shi, Kashiwa-shi, Onsen-gun, Fukuoka, Kurume-shi
2012-07-20
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Sakai, Ageo, Hidaka, Koshigaya, Tokyo, Bunkyล-Ku, Minato-Ku, Yonago
2012-01
Active, closed
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
NCT01349322Breast Cancer
Radiation Therapy Oncology Group
Phase 3
2,354
Shizuoka
2011-05-24
By invitation
Chinese Population Health and Multimorbidity Study
NCT07026370Chronic Respiratory Diseases, Cardiovascular and Cerebrovascular Diseases, Malignant Tumors, Endocrine and Metabolic Diseases
China-Japan Friendship Hospital
Observational
50,991
2011-01-01
Recruiting
International Chronic Myeloid Leukemia Pediatric Study
NCT01281735Chronic Myeloid Leukemia
Poitiers University Hospital
Observational
750
Tokyo
2011-01
Recruiting
Chinese PE Multimodality Imaging Artificial Intelligence Study
NCT06526468Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Disease
China-Japan Friendship Hospital
Observational
1,500
2010-09-01
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT02493478Failed or Difficult Intubation, Sequela, Intubation; Difficult, Intubation Complication
Children's Hospital of Philadelphia
Observational
150,000
Setagaya-Ku, Hiroshima, Kobe, ลŒbu, Saitama, Shimotsuke, Tokyo
2010-03
Active, closed
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
NCT01081951Ovarian Cancer
DrugsTaxol·Olaparib·Paclitaxel·Carboplatin
AstraZeneca
Phase 2
162
Chลซลku, Fukuoka, Matsuyama, Morioka, Shinjuku-ku, Yamagata, Yonago-shi
2010-02-04
Recruiting
Dominantly Inherited Alzheimer Network (DIAN)
NCT00869817Alzheimer's Disease
Washington University School of Medicine
Observational
700
Niigata, Osaka, Tokyo
2009-01
Active, closed
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
NCT00781612Neoplasm Metastasis
DrugsPerjeta·Trastuzumab emtansine·Herceptin·Tecentriq
Genentech, Inc.
Phase 2
378
Hiroshima, Hyลgo
2008-10-16
Recruiting
International Registry of Accidental Hypothermia
NCT06200285Accidental Hypothermia
University Hospital, Geneva
Observational
500
Hokkaido
2008-10-01
Active, closed
Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil
NCT01475123Coronary Artery Disease, End Stage Renal Disease
DrugNicorandil
Kumamoto University
Phase 4
268
Kumamoto
2008-06
Recruiting
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
NCT02889666Recurrent Non-small Cell Lung Cancer
DrugsGemcitabine/Cisplatin·Docetaxel·Cisplatin·Carboplatin
Shanghai Jiao Tong University School of Medicine
Phase 1
500
2008-01
Active, closed
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00565851Clear Cell Adenocarcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
DrugsDocetaxel·Gemcitabine·Paclitaxel·Bevacizumab
National Cancer Institute (NCI)
Phase 3
1,052
Sendai, Kure, Sapporo, Shiwa-gun, Kagoshima, Niigata, Shizuoka, Shinjuku-ku
2007-12-06
Active, closed
Psoriasis Longitudinal Assessment and Registry
NCT00508547Psoriasis
Janssen Scientific Affairs, LLC
Observational
20,167
Hirakata, Hokkaido, Itabashi Ku, Kobe, Kurume, Matsumoto, ลŒita, Takamatsu
2007-06-21
Recruiting
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
NCT01257269Thrombotic Thrombocytopenic Purpura, Congenital Thrombotic Thrombocytopenic Purpura, Familial Thrombotic Thrombocytopenic Purpura, Thrombotic Thrombocytopenic Purpura, Congenital
Insel Gruppe AG, University Hospital Bern
Observational
450
Kashihara
2006-10
Active, closed
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
NCT00336063Adult Nasal Type Extranodal NK/T-Cell Lymphoma, Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
DrugsVorinostat·Azacitidine
National Cancer Institute (NCI)
Phase 1
18
Tokyo
2006-03-03
Recruiting
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
NCT06476067Esophageal Cancer, Recurrence, DNA Methylation
City of Hope Medical Center
Observational
150
Nagoya, Chลซล
2006-01-01
Recruiting
The Chinese Familial Alzheimer's Network
NCT03657732Alzheimer Disease, Familial Alzheimer Disease (FAD)
Capital Medical University
Observational
40,000
2005-01-10
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Ginowan, Kyoto
2004-09-15
Recruiting
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
NCT06490003Esophageal Squamous Cell Carcinoma, Chemotherapy Effect, DNA Methylation
DrugCisplatin
City of Hope Medical Center
Observational
150
Chลซล
2004-06-01
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
NCT00196742Fabry Disease
Genzyme, a Sanofi Company
Observational
9,000
Kobe, Nankoku, Chiba, Niigata, Osaka, Tokyo
2001-07-31
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
NCT02832245Venous Thromboembolism
Manuel Monreal
Observational
120,000
Kitakyushu, Maebashi, Amagasaki, Kumamoto, Kyoto, Tsu, Nagasaki, Osaka
2001-03
Recruiting
China Cognition and Aging Study
NCT03653156Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD)
Capital Medical University
Observational
100,000
2000-01-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Yonago, Chiba, Osaka, Tokyo
1991-04-01
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Medtronic
Observational
20,000
Ageo, Bunkyล City, Gifu, Hidaka, Hiroshima, Kagoshima, Kamakura, Kawasaki
1983-01
Rows per page Showing 2401–2472 of 2472
Previous 23 24 25
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-japan?page=25

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,472 studies in total at the last sync on 26 Sep 2026, 19:48 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Japan?

1,255 of the 2,472 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:48 UTC sync. A further 104 have not yet opened recruitment, 1,055 are active but closed to new participants, and 58 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Multiple Myeloma (48) Breast Cancer (48) Non-Small Cell Lung Cancer (41) Obesity (37) Carcinoma, Non-Small-Cell Lung (32) Non-small Cell Lung Cancer (30) Crohn's Disease (26) Ulcerative Colitis (25) Solid Tumors (24) Gastric Cancer (23) Prostate Cancer (23) Advanced Solid Tumor (22) Overweight (21) Hepatocellular Carcinoma (21) Systemic Lupus Erythematosus (20)
→

Browse trials by site location

Fukuoka (550) Nagoya (510) Sapporo (402) Tokyo (363) Osaka (345) Chiba (322) Kashiwa (312) Yokohama (268) Kobe (235) Kyoto (234) Hiroshima (221) Sendai (205) Chลซลku (202) Matsuyama (171) Bunkyล City (169)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.